Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03230565 · ClinicalTrials.gov registry record · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
A Phase 4 study of Pain, Postoperative and Surgical Procedure, Unspecified, sponsored by Stanford University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT03230565 is a Phase 4 study of Pain, Postoperative and Surgical Procedure, Unspecified that is actively recruiting participants, run by Stanford University. The registered enrollment target is 240 participants, below the 270-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (11% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03230565, a Phase 4 study of Pain, Postoperative and Surgical Procedure, Unspecified, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the study is to compare continuous infusions and scheduled bolus infusions for peripheral nerve blocks and their effect on post-surgical pain.
Conditions Studied
Interventions
- DRUG Ropivacaine
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2026-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03230565
The ClinicalTrials.gov registry entry for NCT03230565 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 270-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (11% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 1 intervention - of which Ropivacaine is the first listed.
NCT03230565 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03230565 about?
NCT03230565 is a clinical study titled "Continuous Infusions vs Scheduled Bolus Infusions". The goal of the study is to compare continuous infusions and scheduled bolus infusions for peripheral nerve blocks and their effect on post-surgical pain.
What is the current status of trial NCT03230565?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 240 participants. The study started on 2018-06-01. Estimated completion is 2026-12.
What conditions does trial NCT03230565 study?
This clinical trial studies the following conditions: Pain, Postoperative, Surgical Procedure, Unspecified.
What interventions are being tested in trial NCT03230565?
The interventions under investigation include: Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT03230565?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03230565 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia
RECRUITING · Phase 4
-
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
RECRUITING · Phase 4
-
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
RECRUITING · Phase 4
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
RECRUITING · Phase 4
-
IPACK on Early Pain Scores After ACL Reconstruction
RECRUITING · Phase 4
-
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.